使い捨て内視鏡市場規模、シェア、動向、2030年までの世界予測

使い捨て内視鏡市場 -タイプ（消化管内視鏡、泌尿器科内視鏡、喉頭鏡）、臨床用途（診断、外科）、用途（泌尿器科、消化器科、耳鼻咽喉科内視鏡）、エンドユーザー（病院、ASC、クリニック）、地域別 – 2030年までの世界予測

世界の使い捨て内視鏡市場は、2025年の9億5,000万米ドルから2030年には26億7,000万米ドルに達し、2025年から2030年にかけて22.9%のCAGRで成長すると予測されています。

使い捨て内視鏡市場は、慢性疾患の有病率上昇、低侵襲手術への需要増加、そして画像技術および光学技術の継続的な進歩に牽引され、力強い成長を遂げています。新興市場は、医療インフラの改善、手術件数の増加、そして医療ツーリズムの成長により、高度な内視鏡ソリューションの普及を促進する大きな機会を提供しています。しかしながら、市場の成長は、感染リスク、不十分な滅菌・再処理方法、高額な手術費用といった課題に直面しており、特にコスト重視でリソースが限られた医療現場では、普及が制限される可能性があります。

調査範囲

本レポートは、使い捨て内視鏡市場を種類、用途、臨床用途、エンドユーザー、地域の観点から分析しています。また、市場成長に影響を与える推進要因、制約要因、機会、課題といった要因を考察し、市場リーダーの競争環境の概要を示しています。さらに、ミクロ市場を個別の成長傾向に基づいて分析し、5つの主要地域とそれぞれの国における市場セグメントの収益予測も行っています。

レポートを購入する理由

本レポートは、既存企業と中小規模企業の両方にとって市場理解を深め、ひいては市場シェアの拡大に役立ちます。本レポートを購入した企業は、以下に示す戦略のいずれか、または組み合わせて活用することで、市場におけるプレゼンスを強化できます。

本レポートでは、以下の点について考察します。

主要な推進要因（政府およびその他の組織による投資、資金、助成金の増加、病院による内視鏡ユニットの拡充への注力の高まり、低侵襲手術への関心の高まり、対象疾患の診断・治療における内視鏡検査の必要性の高まり）、制約要因（内視鏡検査にかかる高額な間接費）、機会（新興国における医療セクターの急速な発展）、課題（医療廃棄物処理に関する環境問題、限定的な償還政策）の分析

• 市場浸透：使い捨て内視鏡市場における主要企業の製品ラインナップに関する徹底的な知識
• 製品開発／イノベーション：使い捨て内視鏡市場における今後のトレンド、研究開発の取り組み、新製品投入に関する包括的な理解
• 市場開拓：収益性の高い発展途上地域に関する徹底的な知識
• 市場多様化：新製品、拡大する地域、使い捨て内視鏡業界における最新の変化に関する徹底的な知識は、市場の多様化に貢献します
• 競合評価：オリンパス株式会社（日本）、ボストン・サイエンティフィック株式会社（米国）、HOYA株式会社（日本）、Ambu A/s（デンマーク）、Karl Storz SE & Co. KG（ドイツ）、Hunan Vathin Medical Instrument Co., Ltd.（中国）、Zhuhai Pusen Medical Technology Co., Ltd.（中国）など、主要企業の市場シェア、成長戦略、製品ラインナップに関する詳細な評価

Report Description

The global disposable endoscopes market is projected to reach USD 2.67 billion by 2030, growing from USD 0.95 billion in 2025, at a CAGR of 22.9% from 2025 to 2030.

The disposable endoscopes market is experiencing strong growth driven by the rising prevalence of chronic diseases, increasing demand for minimally invasive procedures, and ongoing advancements in imaging and optical technologies. Emerging markets offer substantial opportunities due to improving healthcare infrastructure, expanding procedure volumes, and the growth of medical tourism, which facilitate the wider adoption of advanced endoscopic solutions. However, market growth faces challenges such as infection risks, insufficient sterilization and reprocessing practices, and high procedural costs, which may limit broader adoption—particularly in cost-sensitive and resource-limited healthcare settings.

The bronchoscopes segment accounted for the second-largest growth in the disposable endoscopes market in 2024.

By type, the disposable endoscopes market is divided into urology endoscopes, bronchoscopes, cystoscopes, laryngoscopes, GI endoscopes, arthroscopes, and other disposable endoscopes. Among these, the bronchoscopes segment held the second-largest market share in 2024, driven by the increasing global incidence of respiratory diseases, especially lung cancer. According to the American Cancer Society, in 2025, the US is expected to see about 226,650 new lung cancer cases and 124,730 related deaths, while the World Cancer Research Fund reported 2,480,675 new cases worldwide in 2022. This rising disease burden has significantly boosted the demand for bronchoscopy procedures for early diagnosis and treatment. Disposable bronchoscopes are increasingly chosen because they help prevent cross-contamination, eliminate the need for reprocessing, and ensure consistent performance in emergency and intensive care situations. Additionally, advancements in imaging technology and maneuverability, along with growing adoption by hospitals and outpatient clinics, are further driving the growth of this segment, making bronchoscopes the second largest contributor to the disposable endoscopes market.

The surgical segment accounted for the largest share of the disposable endoscopes market in 2024.

By clinical practice, the disposable endoscopes market is divided into diagnostic and surgical uses. In 2024, the surgical use segment held the largest market share. This growth is driven by the rising adoption of minimally invasive surgical procedures across various specialties, including gastroenterology, urology, pulmonology, and gynecology. Surgeons favor disposable endoscopes for their superior sterility, reliable performance, and ability to eliminate risks associated with cross-contamination and reprocessing errors. The increasing prevalence of chronic conditions such as cancer, kidney disorders, and respiratory diseases has led to a rise in surgical procedures that require precise visualization and dependable instrumentation. Additionally, the availability of advanced single-use endoscopes with high-definition imaging and ergonomic designs improves procedural efficiency and safety. Hospitals and outpatient surgical centers are increasingly shifting toward single-use devices to enhance infection control and streamline operations. Collectively, these factors establish the surgical usage segment as the leading contributor to the disposable endoscopes market by clinical application.

Europe accounted for the second-largest position in the disposable endoscopes market during the forecast period.

The global disposable endoscopes market is divided into five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, Europe held the second-largest share in this market. This is due to a mix of demographic trends, high disease rates, and advanced healthcare systems. The region is experiencing notable population aging, with Germany’s population aged 65 and older projected to increase by 41% to 24 million by 2050. Additionally, 19% of the UK population was already over 65 in 2022, leading to higher demand for diagnostic and minimally invasive procedures. The growing burden of chronic diseases and cancer also drives the need for disposable endoscopes, with 53.7% of adults in Germany reporting chronic conditions in 2024, and cancer-related deaths reaching 138,579 in England (2022) and 230,292 in Germany (2023). Coupled with well-established hospitals, the adoption of advanced medical technology, and supportive regulatory frameworks, these factors together create a strong market environment, making Europe a key growth region in the global disposable endoscopes market.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 –40%, Tier 2 –30%, and Tier 3 –30%
• By Designation: C-level –50%, Director level –30%, and Others –20%
• By Region: North America –30%, Europe – 25%, Asia Pacific –20%, Latin America –15%, and Middle East & Africa –10%

Notes:

Companies are classified into tiers based on their total revenue. The tiers are as follows: Tier 1 = > USD 10.0 billion, tier 2 = USD 1.0 billion to USD 10.0 billion, and tier 3 = < USD 1.0 billion C-level primaries include CEOs, CFOs, COOs, and VPs. Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The players operating in the disposable endoscopes market include Olympus Corporation (Japan), Boston Scientific Corporation (US), HOYA Corporation (Japan), Ambu A/s (Denmark),  Karl Storz SE & Co. KG (Germany), Hunan Vathin Medical Instrument Co., Ltd. (China), Zhuhai Pusen Medical Technology Co., Ltd. (China), GI View Ltd (Isareal), Richard Wolf GmbH (Germany), Daichuan medica (China), Scivita Medical (China), Uroviu Corporation (US), Neoscope Inc. (US), Verathon Inc. A Ropper Technologies Company (US), Integrated Endoscopy (US), HUGER Medical Instrument Co., Ltd. (China), Guangzhou Red Pine Medical Instrument Co. Ltd. (China), Nanchang WOEK Medical Technology Co., Ltd (China), Innovex Medical Co., Ltd. (China), Xenocor (US), MacroLux Medical Technology Co., Ltd. (China), THE COOPER COMPANIES, INC. (US), Shenzhen HugeMed Medical Technical Development Co., Ltd. (China), and Xi’an Haiye Medical Equipment Co., Ltd. (China).

Research Coverage

This report examines the disposable endoscopes market based on type, application, clinical use, end user, and region. It also explores factors such as drivers, restraints, opportunities, and challenges influencing market growth, and provides an overview of the competitive landscape for market leaders. Additionally, the report analyzes micro markets concerning their individual growth trends and forecasts the revenue of market segments across five major regions and their respective countries.

Reasons to Buy the Report

The report will help both established and smaller firms understand the market, which, in turn, will assist them in increasing their market share. Firms purchasing the report can use one or a combination of the strategies mentioned below to strengthen their position in the market presence.

This report provides insights into the following pointers:

• Analysis of key drivers (Increasing investments, funds, and grants by government and other organizations, growing focus of hospitals to expand endoscopic units, increasing preference for minimally invasive surgeries, rising need for endoscopy to diagnose & treat target diseases), restraints (High overhead costs of endoscopy procedures), opportunities (Rapidly developing healthcare sector in emerging countries), challenges (Environmental concerns related to medical waste disposal, limited reimbursement policies)
• Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the disposable endoscopes market
• Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the disposable endoscopes market
• Market Development: Complete knowledge about profitable developing regions
• Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the disposable endoscopes industry help to diversify the market
• Competitive Assessment: In-depth assessment of market share, growth strategies and product offerings of leading players like Olympus Corporation (Japan), Boston Scientific Corporation (US), HOYA Corporation (Japan), Ambu A/s (Denmark), Karl Storz SE & Co. KG (Germany), Hunan Vathin Medical Instrument Co., Ltd. (China), Zhuhai Pusen Medical Technology Co., Ltd. (China), and among others.

Table of Contents

1               INTRODUCTION              25

1.1           STUDY OBJECTIVES       25

1.2           MARKET DEFINITION   25

1.3           STUDY SCOPE   26

1.3.1        MARKETS COVERED & REGIONAL SEGMENTATION                 26

1.3.2        INCLUSIONS & EXCLUSIONS       26

1.3.3        YEARS CONSIDERED      27

1.3.4        CURRENCY CONSIDERED            27

1.4           STAKEHOLDERS               28

2               EXECUTIVE SUMMARY  29

2.1           KEY INSIGHTS & MARKET HIGHLIGHTS 29

2.2           KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS              30

2.3           DISRUPTIVE TRENDS SHAPING MARKET GROWTH                 31

2.4           HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS                 32

2.5           SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST                33

3               PREMIUM INSIGHTS       34

3.1           DISPOSABLE ENDOSCOPES MARKET OVERVIEW                 34

3.2           NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET,  BY END USER     35

3.3           GEOGRAPHIC SNAPSHOT OF DISPOSABLE ENDOSCOPES MARKET (2024)    36

3.4          GEOGRAPHIC MIX: DISPOSABLE ENDOSCOPES MARKET,  2025–2030 (USD MILLION)            36

3.5           DISPOSABLE ENDOSCOPES MARKET: DEVELOPING VS. DEVELOPED MARKETS 37

4               MARKET OVERVIEW       38

4.1           INTRODUCTION              38

4.2           MARKET DYNAMICS       38

4.2.1        DRIVERS               38

4.2.1.1    Growing demand for infection control and regulatory push                 38

4.2.1.2    Rising burden of chronic diseases      39

4.2.2        RESTRAINTS      39

4.2.2.1    Environmental impact and sustainability concerns         39

4.2.3        OPPORTUNITIES              40

4.2.3.1    Rapidly developing healthcare sector in emerging economies                 40

4.2.4        CHALLENGES    40

4.2.4.1    High upfront expenditure per procedure          40

4.3           UNMET NEEDS & WHITE SPACES              41

4.3.1        UNMET NEEDS IN DISPOSABLE ENDOSCOPES MARKET                 41

4.3.2        WHITE SPACE OPPORTUNITIES                41

4.4           INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNTIES               42

4.4.1        INTERCONNECTED MARKETS   42

4.4.2        CROSS-SECTOR OPPORTUNTIES              42

4.5           STRATEGIC MOVES BY TIER-1/2/3 PLAYERS        42

5               INDUSTRY TRENDS         43

5.1           PORTER’S FIVE FORCES ANALYSIS           43

5.1.1        THREAT OF NEW ENTRANTS      44

5.1.2        THREAT OF SUBSTITUTES          44

5.1.3        BARGAINING POWER OF BUYERS             45

5.1.4        BARGAINING POWER OF SUPPLIERS       45

5.1.5        INTENSITY OF COMPETITIVE RIVALRY 45

5.2           MACROECONOMIC OUTLOOK  45

5.2.1        INTRODUCTION              45

5.2.2        GDP TRENDS AND FORECAST   45

5.2.3        TRENDS IN GLOBAL ENDOSCOPY EQUIPMENT IDUSTRY              47

5.2.4        TRENDS IN GLOBAL FLEXIBLE ENDOSCOPES INDUSTRY                 47

5.3           SUPPLY CHAIN ANALYSIS             47

5.4           VALUE CHAIN ANALYSIS               49

5.5           ECOSYSTEM ANALYSIS  50

5.6           PRICING ANALYSIS          51

5.6.1        AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES,  BY KEY PLAYER (2022–2024)        51

5.6.2        AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES,  BY TYPE (2022–2024)      52

5.6.3        AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES,  BY REGION (2022–2024)                 53

5.7           TRADE ANALYSIS             53

5.7.1        IMPORT SCENARIO (HS CODE 9018)        53

5.7.2        EXPORT DATA (HS CODE 9018) 54

5.8           KEY CONFERENCES & EVENTS, 2025–2027              55

5.9           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       56

5.10         INVESTMENT & FUNDING SCENARIO     57

5.11         CASE STUDY ANALYSIS 57

5.11.1      CASE STUDY 1: ICU BRONCHOSCOPY PERFORMANCE AND ADOPTION               57

5.11.2      CASE STUDY 2: ERCP INFECTION‑CONTROL CONVERSION PATHWAY               58

5.11.3      CASE STUDY 3: OPTIMIZING TRANSBRONCHIAL CRYOBIOPSY IN INTERSTITIAL LUNG DISEASE USING AMBU ASCOPE 5 BRONCHO HD              58

5.12         IMPACT OF 2025 US TARIFFS ON DISPOSABLE ENDOSCOPES MARKET 59

5.12.1      INTRODUCTION              59

5.12.2      KEY TARIFF RATES          60

5.12.3      PRICE IMPACT ANALYSIS             60

5.12.4      IMPACT ON COUNTRIES/REGIONS         61

5.12.4.1  North America      61

5.12.4.2  Europe   61

5.12.4.3  Asia Pacific            61

5.12.5      END-USE INDUSTRY IMPACT     61

6               TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 62

6.1           KEY EMERGING TECHNOLOGIES              62

6.1.1        CMOS & CCD IMAGING SENSORS              62

6.1.2        FIBER-OPTIC ILLUMINATION SYSTEMS 62

6.2           COMPLEMENTARY TECHNOLOGIES       62

6.2.1        AI-ASSISTED IMAGE PROCESSING AND VISUALIZATION                 63

6.3           TECHNOLOGY/PRODUCT ROADMAP    63

6.3.1        SHORT TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 63

6.3.2        MID TERM (2027–2030) | EXPANSION & STANDARDIZATION       63

6.3.3        LONG TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 64

6.4           PATENT ANALYSIS          64

6.4.1        INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS            65

6.5           FUTURE APPLICATIONS               67

6.5.1        AI-ENABLED VISUALIZATION AND DIAGNOSTIC SUPPORT             67

6.5.2        BIODEGRADABLE & ECO-FRIENDLY ENDOSCOPES                 67

6.5.3        SMART ENDOSCOPES WITH EMBEDDED SENSORS                 68

6.6           IMPACT OF AI/GEN AI ON DISPOSABLE ENDOSCOPES MARKET               68

6.6.1        TOP USE CASES & MARKET POTENTIAL                 68

6.7           BEST PRACTICES IN DISPOSABLE ENDOSCOPES PROCESSING     69

6.7.1        CASE STUDIES OF AI IMPLEMENTATION IN DISPOSABLE ENDOSCOPES MARKET      69

6.7.2        INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS   69

6.7.3        CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN DISPOSABLE ENDOSCOPES MARKET      70

7               SUSTAINABILITY & REGULATORY LANDSCAPE 71

7.1           REGIONAL REGULATIONS & COMPLIANCE          71

7.1.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             71

7.1.2        INDUSTRY STANDARDS                73

7.2           SUSTAINABILITY INITIATIVES   74

7.2.1        CARBON IMPACT AND ECO-APPLICATIONS OF DISPOSABLE ENDOSCOPES        74

7.2.1.1    Carbon impact reduction    74

7.2.1.2    Eco-applications   74

7.3           SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES       74

7.4           CERTIFICATIONS, LABELING, AND ECO-STANDARDS                 75

8               CUSTOMER LANDSCAPE & BUYER BEHAVIOR    76

8.1           DECISION-MAKING PROCESS     76

8.2           BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA             76

8.2.1        KEY STAKEHOLDERS IN BUYING PROCESS           76

8.2.2        KEY BUYING CRITERIA  77

8.3           ADOPTION BARRIERS & INTERNAL CHALLENGES                 78

8.4           UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES                 78

8.5           MARKET PROFITABILITY             78

8.5.1        REVENUE POTENTIAL   79

8.5.2        COST DYNAMICS             79

8.5.3        MARGIN OPPORTUNITIES IN KEY APPLICATIONS                 79

9               DISPOSABLE ENDOSCOPES MARKET, BY TYPE  80

9.1           INTRODUCTION              81

9.2           UROLOGY ENDOSCOPES              81

9.2.1        UROLOGY ENDOSCOPES SEGMENT TO HOLD MAJOR SHARE OF MARKET         81

9.3           BRONCHOSCOPES           82

9.3.1        RISING PREVALENCE OF LUNG CANCER TO BOOST SEGMENTAL GROWTH  82

9.4           CYSTOSCOPES  84

9.4.1        GROWING BURDEN OF BLADDER CANCER TO AID SEGMENTAL GROWTH  84

9.5           GI ENDOSCOPES              85

9.5.1        STRINGENT REGULATORY RECOMMENDATIONS FROM US FDA TO ACCELERATE SHIFT TOWARD SINGLE-USE GI ENDOSCOPES   85

9.6           LARYNGOSCOPES            86

9.6.1        RISING INFECTION CONTROL AND INCREASING LARYNGEAL DISORDER BURDEN TO DRIVE SEGMENTAL GROWTH             86

9.7           ARTHROSCOPES               87

9.7.1        RISING GERIATRIC POPULATION AND GROWING INCIDENCE OF ORTHOPEDIC DISEASES TO BOOST MARKET GROWTH             87

9.8           OTHER DISPOSABLE ENDOSCOPES        88

10            DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE  90

10.1         INTRODUCTION              91

10.2         SURGICAL USAGE            91

10.2.1      RISING ADOPTION OF MINIMALLY INVASIVE SURGERIES TO DRIVE SEGMENTAL GROWTH    91

10.3         DIAGNOSTIC USAGE      92

10.3.1      RISING PREFERENCE FOR SAFE AND EFFICIENT DIAGNOSTIC PROCEDURES TO DRIVE ADOPTION OF DISPOSABLE ENDOSCOPES        92

11            DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION                 94

11.1         INTRODUCTION              95

11.2         UROLOGY           95

11.2.1      RISING PREVALENCE OF URINARY TRACT DISEASES AND CANCERS TO AID MARKET GROWTH           95

11.3         BRONCHOSCOPY             96

11.3.1      RISING INFECTION CONTROL NEEDS TO DRIVE GROWTH OF BRONCHOSCOPY SEGMENT            96

11.4         GASTROENTEROLOGY 97

11.4.1      TECHNOLOGICAL ADVANCEMENTS AND GROWING PROCEDURAL VOLUMES IN HOSPITAL ENDOSCOPY UNITS TO FUEL DEMAND 97

11.5         ENT        99

11.5.1      ABILITY OF DISPOSABLE ENT ENDOSCOPES TO REDUCE CROSS-CONTAMINATION RISKS TO DRIVE DEMAND                 99

11.6         OTHER APPLICATIONS 100

12            DISPOSABLE ENDOSCOPES MARKET, BY END USER                 101

12.1         INTRODUCTION              102

12.2         HOSPITALS         102

12.2.1      HOSPITALS TO DOMINATE DISPOSABLE ENDOSCOPES MARKET DURING FORECAST PERIOD    102

12.3         AMBULATORY SURGERY CENTERS          103

12.3.1      GROWING PREFERENCE FOR OUTPATIENT SURGERIES AND TECHNOLOGICAL ADVANCEMENTS TO ACCELERATE GROWTH             103

12.4         CLINICS                104

12.4.1      RISING ADOPTION OF OUTPATIENT DIAGNOSTICS AND MINOR PROCEDURES TO DRIVE SEGMENTAL GROWTH                 104

12.5         OTHER END USERS         105

13            DISPOSABLE ENDOSCOPES MARKET, BY REGION                 107

13.1         INTRODUCTION              108

13.2         NORTH AMERICA             109

13.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 110

13.2.2      US           113

13.2.2.1  US to dominate North American disposable endoscopes market during forecast period          113

13.2.3      CANADA               115

13.2.3.1  Stringent infection control standards and rising chronic disease burden to adoption of disposable endoscopes 115

13.3         EUROPE               117

13.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      117

13.3.2      GERMANY           120

13.3.2.1  Germany to dominate European disposable endoscopes market                 120

13.3.3      UK          122

13.3.3.1  Growing aging population and infection control focus to boost market    122

13.3.4      FRANCE                123

13.3.4.1  Increase in health expenditure and high prevalence of cancer to stimulate market growth      123

13.3.5      ITALY    125

13.3.5.1  Increasing aging population and prevalence of chronic diseases to boost adoption of disposable endoscopes         125

13.3.6      SPAIN    127

13.3.6.1  Rising aging population to drive market growth              127

13.3.7      REST OF EUROPE             128

13.4         ASIA PACIFIC     130

13.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 130

13.4.2      CHINA  133

13.4.2.1  China to account for largest share of APAC region in disposable endoscopes market               133

13.4.3      JAPAN   135

13.4.3.1  Increasing chronic diseases and geriatric population to drive Japan’s growth in market    135

13.4.4      INDIA    137

13.4.4.1  Rising disease burden and aging population to position India as key growth hub in Asia Pacific           137

13.4.5      AUSTRALIA         138

13.4.5.1  Rising cancer burden and expanding screening programs to support disposable endoscopes adoption in Australia    138

13.4.6      SOUTH KOREA  140

13.4.6.1  Robust cancer screening programs to drive strong adoption of disposable endoscopes         140

13.4.7      REST OF ASIA PACIFIC   142

13.5         LATIN AMERICA                143

13.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 143

13.5.2      BRAZIL 146

13.5.2.1  Brazil to account for largest share of LATAM market in 2024                 146

13.5.3      MEXICO                148

13.5.3.1  Expanding healthcare infrastructure to strengthen Mexico’s position in global market     148

13.5.4      REST OF LATIN AMERICA             149

13.6         MIDDLE EAST & AFRICA                151

13.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 151

13.6.2      GCC COUNTRIES              153

13.6.2.1  Increasing healthcare investments and hospital expansions to drive market growth             153

13.6.3      REST OF MIDDLE EAST & AFRICA             155

14            COMPETITIVE LANDSCAPE         158

14.1         INTRODUCTION              158

14.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            158

14.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET                 158

14.3         REVENUE ANALYSIS, 2020–2024  159

14.4         MARKET SHARE ANALYSIS, 2024                 160

14.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 162

14.5.1      STARS   162

14.5.2      EMERGING LEADERS     163

14.5.3      PERVASIVE PLAYERS      163

14.5.4      PARTICIPANTS 163

14.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         165

14.5.5.1  Company footprint               165

14.5.5.2  Region footprint   165

14.5.5.3  Type footprint       166

14.5.5.4  Application footprint            167

14.5.5.5  End-user footprint                167

14.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        168

14.6.1      PROGRESSIVE COMPANIES         168

14.6.2      RESPONSIVE COMPANIES            168

14.6.3      DYNAMIC COMPANIES  168

14.6.4      STARTING BLOCKS         168

14.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 169

14.6.5.1  Detailed list of key startups/SMEs    169

14.6.5.2  Competitive benchmarking of key startups/SMEs          171

14.7         COMPANY VALUATION & FINANCIAL METRICS 172

14.7.1      FINANCIAL METRICS      172

14.7.2      COMPANY VALUATION 172

14.8         BRAND/PRODUCT COMPARISON             173

14.9         COMPETITIVE SCENARIO             173

14.9.1      PRODUCT LAUNCHES & APPROVALS     173

14.9.2      DEALS  176

14.9.3      EXPANSIONS     178

15            COMPANY PROFILES      179

15.1         KEY PLAYERS     179

15.1.1      AMBU A/S            179

15.1.1.1  Business overview 179

15.1.1.2  Products offered   180

15.1.1.3  Recent developments           181

15.1.1.3.1                Product launches & approvals            181

15.1.1.3.2                Expansions             183

15.1.1.4  MnM view              184

15.1.1.4.1                Right to win           184

15.1.1.4.2                Strategic choices   184

15.1.1.4.3                Weaknesses & competitive threats     184

15.1.2      BOSTON SCIENTIFIC CORPORATION     185

15.1.2.1  Business overview 185

15.1.2.2  Products offered   186

15.1.2.3  Recent developments           187

15.1.2.3.1                Product approvals 187

15.1.2.3.2                Deals      187

15.1.2.4  MnM view              187

15.1.2.4.1                Right to win           187

15.1.2.4.2                Strategic choices   188

15.1.2.4.3                Weaknesses & competitive threats     188

15.1.3      OLYMPUS CORPORATION           189

15.1.3.1  Business overview 189

15.1.3.2  Products offered   190

15.1.3.3  Recent developments           190

15.1.3.3.1                Product approvals 190

15.1.3.3.2                Deals      191

15.1.3.4  MnM view              191

15.1.3.4.1                Right to win           191

15.1.3.4.2                Strategic choices   191

15.1.3.4.3                Weaknesses & competitive threats     191

15.1.4      HOYA CORPORATION   192

15.1.4.1  Business overview 192

15.1.4.2  Products offered   193

15.1.4.3  Recent developments           194

15.1.4.3.1                Deals      194

15.1.4.4  MnM view              194

15.1.4.4.1                Right to win           194

15.1.4.4.2                Strategic choices   194

15.1.4.4.3                Weaknesses & competitive threats     194

15.1.5      VERATHON INC.               195

15.1.5.1  Business overview 195

15.1.5.2  Products offered   195

15.1.5.3  Recent developments           196

15.1.5.3.1                Product launches  196

15.1.5.4  MnM view              196

15.1.5.4.1                Right to win           196

15.1.5.4.2                Strategic choices   197

15.1.5.4.3                Weaknesses & competitive threats     197

15.1.6      KARL STORZ SE & CO. KG             198

15.1.6.1  Business overview 198

15.1.6.2  Products offered   198

15.1.6.3  Recent developments           199

15.1.6.3.1                Product launches  199

15.1.6.3.2                Deals      199

15.1.7      HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.                 200

15.1.7.1  Business overview 200

15.1.7.2  Products offered   200

15.1.7.3  Recent developments           202

15.1.7.3.1                Deals      202

15.1.8      INNOVEX MEDICAL CO., LTD.    203

15.1.8.1  Business overview 203

15.1.8.2  Products offered   203

15.1.9      SCIVITA MEDICAL           205

15.1.9.1  Business overview 205

15.1.9.2  Products offered   205

15.1.10   GUANGZHOU RED PINE MEDICAL INSTRUMENT CO., LTD.      206

15.1.10.1                 Business overview 206

15.1.10.2                 Products offered   206

15.2         OTHER PLAYERS              207

15.2.1      THE COOPER COMPANIES, INC.                207

15.2.2      ZHUHAI PUSEN MEDICAL TECHNOLOGY CO., LTD.                 208

15.2.3      UROVIU CORPORATION               209

15.2.4      OTU MEDICAL  210

15.2.5      GI VIEW LTD.     211

15.2.6      TSC LIFE              212

15.2.7      RICHARD WOLF GMBH 213

15.2.8      DAICHUAN MEDICA       214

15.2.9      NEOSCOPE INC.                215

15.2.10   INTEGRATED ENDOSCOPY         216

15.2.11   HUGER MEDICAL INSTRUMENT CO., LTD.           216

15.2.12   XENOCOR            217

15.2.13   MACROLUX MEDICAL TECHNOLOGY CO., LTD.                 218

15.2.14   SHENZHEN HUGEMED MEDICAL TECHNICAL DEVELOPMENT CO., LTD.            219

15.2.15   ZHEJIANG GEYI MEDICAL DEVICES CO., LTD.     220

16            RESEARCH METHODOLOGY       221

16.1         RESEARCH DATA              221

16.1.1      SECONDARY DATA          221

16.1.1.1  Key data from secondary sources       223

16.1.2      PRIMARY DATA 223

16.1.2.1  Key data from primary sources           225

16.1.2.2  Key industry insights           226

16.2         MARKET SIZE ESTIMATION         227

16.3         MARKET BREAKDOWN & DATA TRIANGULATION                 232

16.4         MARKET RANKING ANALYSIS     232

16.5         STUDY ASSUMPTIONS  233

16.6         RESEARCH LIMITATIONS             233

16.6.1      METHODOLOGY-RELATED LIMITATIONS           233

16.6.2      SCOPE-RELATED LIMITATIONS                 233

16.7         RISK ASSESSMENT           234

17            APPENDIX           235

17.1         DISCUSSION GUIDE        235

17.2         KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL                241

17.3         CUSTOMIZATION OPTIONS        243

17.4         RELATED REPORTS         243

17.5         AUTHOR DETAILS           244

LIST OF TABLES

TABLE 1                DISPOSABLE ENDOSCOPES MARKET: INCLUSIONS & EXCLUSIONS       26

TABLE 2                STANDARD CURRENCY CONVERSION RATES                 28

TABLE 3                DISPOSABLE ENDOSCOPES MARKET: PORTER’S FIVE FORCES ANALYSIS 43

TABLE 4                GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030              46

TABLE 5                AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY KEY PLAYER,  2022–2024 (USD)                 51

TABLE 6                AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY TYPE,

2022–2024 (USD)                52

TABLE 7                AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY REGION,  2022–2024 (USD)                 53

TABLE 8                IMPORT DATA FOR DISPOSABLE ENDOSCOPE PRODUCTS UNDER HS CODE 9018,  BY COUNTRY, 2019–2024 (USD THOUSAND)           54

TABLE 9                EXPORT DATA FOR DISPOSABLE ENDOSCOPE PRODUCTS UNDER HS CODE 9018,  BY COUNTRY, 2019–2024 (USD THOUSAND)           54

TABLE 10              DISPOSABLE ENDOSCOPES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2025–2027)                 55

TABLE 11              US-ADJUSTED RECIPROCAL TARIFF RATES                 60

TABLE 12              KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ORTHODONTIC SUPPLIES 60

TABLE 13              DISPOSABLE ENDOSCOPES MARKET: LIST OF PATENTS, 2022−2025      66

TABLE 14              TOP USE CASES & MARKET POTENTIAL                 68

TABLE 15              DISPOSABLE ENDOSCOPES MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION    69

TABLE 16              INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS  69

TABLE 17              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND  OTHER ORGANIZATIONS                 71

TABLE 18              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           71

TABLE 19              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND  OTHER ORGANIZATIONS                 72

TABLE 20              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND  OTHER ORGANIZATIONS                 72

TABLE 21              MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             73

TABLE 22              GLOBAL STANDARDS IN DISPOSABLE ENDOSCOPES MARKET 73

TABLE 23              CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN DISPOSABLE ENDOSCOPES MARKET      75

TABLE 24              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DISPOSABLE ENDOSCOPES           77

TABLE 25              KEY BUYING CRITERIA FOR TOP THREE DISPOSABLE ENDOSCOPE TYPES             77

TABLE 26              DISPOSABLE ENDOSCOPES MARKET: UNMET NEEDS/END-USER EXPECTATIONS          78

TABLE 27              DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            81

TABLE 28              UROLOGY ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     82

TABLE 29              BRONCHOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            83

TABLE 30              CYSTOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       84

TABLE 31              GI ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       86

TABLE 32              LARYNGOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       87

TABLE 33              ARTHROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       88

TABLE 34              OTHER DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            89

TABLE 35              DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            91

TABLE 36              DISPOSABLE ENDOSCOPES MARKET FOR SURGICAL USAGE, BY COUNTRY,

2023–2030 (USD MILLION)            92

TABLE 37              DISPOSABLE ENDOSCOPES MARKET FOR DIAGNOSTIC USAGE, BY COUNTRY,  2023–2030 (USD MILLION)                 93

TABLE 38              DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            95

TABLE 39              DISPOSABLE ENDOSCOPES MARKET FOR UROLOGY APPLICATIONS, BY COUNTRY,  2023–2030 (USD MILLION)            96

TABLE 40              DISPOSABLE ENDOSCOPES MARKET FOR BRONCHOSCOPY APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               97

TABLE 41              DISPOSABLE ENDOSCOPES MARKET FOR GASTROENTEROLOGY APPLICATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)       98

TABLE 42              DISPOSABLE ENDOSCOPES MARKET FOR ENT APPLICATIONS, BY COUNTRY,  2023–2030 (USD MILLION)                 99

TABLE 43              DISPOSABLE ENDOSCOPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2023–2030 (USD MILLION)            100

TABLE 44              DISPOSABLE ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                102

TABLE 45              DISPOSABLE ENDOSCOPES MARKET FOR HOSPITALS, BY COUNTRY,

2023–2030 (USD MILLION)            103

TABLE 46              DISPOSABLE ENDOSCOPES MARKET FOR AMBULATORY SURGERY CENTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               104

TABLE 47              DISPOSABLE ENDOSCOPES MARKET FOR CLINICS, BY COUNTRY,

2023–2030 (USD MILLION)            105

TABLE 48              DISPOSABLE ENDOSCOPES MARKET FOR OTHER END USERS, BY COUNTRY,  2023–2030 (USD MILLION)                 106

TABLE 49              DISPOSABLE ENDOSCOPES MARKET, BY REGION, 2023–2030 (USD MILLION)          109

TABLE 50              DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS)  109

TABLE 51              NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            111

TABLE 52              NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            111

TABLE 53              NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (THOUSAND UNITS)  112

TABLE 54              NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,  2023–2030 (USD MILLION)                 112

TABLE 55              NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            112

TABLE 56              NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            113

TABLE 57              US: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                114

TABLE 58              US: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            114

TABLE 59              US: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            114

TABLE 60              US: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            115

TABLE 61              CANADA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            115

TABLE 62              CANADA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            116

TABLE 63              CANADA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            116

TABLE 64              CANADA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            116

TABLE 65              EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            118

TABLE 66              EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            118

TABLE 67              EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (THOUSAND UNITS)  119

TABLE 68              EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            119

TABLE 69              EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            119

TABLE 70              EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            120

TABLE 71             GERMANY: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            120

TABLE 72             GERMANY: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            121

TABLE 73             GERMANY: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            121

TABLE 74             GERMANY: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            121

TABLE 75              UK: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                122

TABLE 76              UK: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            122

TABLE 77              UK: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            123

TABLE 78              UK: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            123

TABLE 79              FRANCE: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            124

TABLE 80              FRANCE: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            124

TABLE 81              FRANCE: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            124

TABLE 82              FRANCE: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            125

TABLE 83              ITALY: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                125

TABLE 84              ITALY: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            126

TABLE 85              ITALY: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            126

TABLE 86              ITALY: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            126

TABLE 87              SPAIN: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                127

TABLE 88              SPAIN: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            127

TABLE 89              SPAIN: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            128

TABLE 90              SPAIN: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            128

TABLE 91              REST OF EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            129

TABLE 92              REST OF EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,  2023–2030 (USD MILLION)                 129

TABLE 93              REST OF EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            129

TABLE 94              REST OF EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            130

TABLE 95              ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            131

TABLE 96              ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            131

TABLE 97              ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (THOUSAND UNITS)  132

TABLE 98              ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            132

TABLE 99              ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            132

TABLE 100            ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            133

TABLE 101            CHINA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                134

TABLE 102            CHINA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            134

TABLE 103            CHINA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            134

TABLE 104            CHINA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            135

TABLE 105            JAPAN: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                135

TABLE 106            JAPAN: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            136

TABLE 107            JAPAN: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            136

TABLE 108            JAPAN: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            136

TABLE 109            INDIA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                137

TABLE 110            INDIA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            137

TABLE 111            INDIA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            138

TABLE 112            INDIA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            138

TABLE 113            AUSTRALIA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            139

TABLE 114            AUSTRALIA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            139

TABLE 115            AUSTRALIA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            139

TABLE 116            AUSTRALIA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            140

TABLE 117            SOUTH KOREA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            140

TABLE 118            SOUTH KOREA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            141

TABLE 119            SOUTH KOREA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            141

TABLE 120            SOUTH KOREA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            141

TABLE 121            REST OF ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            142

TABLE 122            REST OF ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,  2023–2030 (USD MILLION)            142

TABLE 123            REST OF ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,  2023–2030 (USD MILLION)            143

TABLE 124            REST OF ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY END USER,  2023–2030 (USD MILLION)            143

TABLE 125            LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            144

TABLE 126            LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            144

TABLE 127            LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (THOUSAND UNITS)  145

TABLE 128            LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            145

TABLE 129            LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            145

TABLE 130            LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            146

TABLE 131            BRAZIL: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            146

TABLE 132            BRAZIL: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            147

TABLE 133            BRAZIL: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            147

TABLE 134            BRAZIL: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            147

TABLE 135            MEXICO: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            148

TABLE 136            MEXICO: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            148

TABLE 137            MEXICO: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            149

TABLE 138            MEXICO: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            149

TABLE 139            REST OF LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            150

TABLE 140            REST OF LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023–2030 (USD MILLION)            150

TABLE 141            REST OF LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,  2023–2030 (USD MILLION)            150

TABLE 142            REST OF LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,  2023–2030 (USD MILLION)            151

TABLE 143            MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY REGION,

2023–2030 (USD MILLION)            151

TABLE 144            MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            152

TABLE 145            MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (THOUSAND UNITS)  152

TABLE 146            MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023–2030 (USD MILLION)            152

TABLE 147            MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,  2023–2030 (USD MILLION)            153

TABLE 148            MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,  2023–2030 (USD MILLION)            153

TABLE 149            GCC COUNTRIES: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            154

TABLE 150            GCC COUNTRIES: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,  2023–2030 (USD MILLION)                 154

TABLE 151            GCC COUNTRIES: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            155

TABLE 152            GCC COUNTRIES: DISPOSABLE ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            155

TABLE 153            REST OF MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 156

TABLE 154            REST OF MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET,

BY CLINICAL USAGE, 2023–2030 (USD MILLION) 156

TABLE 155            REST OF MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       156

TABLE 156            REST OF MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET,

BY END USER, 2023–2030 (USD MILLION)               157

TABLE 157            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET             158

TABLE 158            DISPOSABLE ENDOSCOPES MARKET: DEGREE OF COMPETITION           161

TABLE 159            DISPOSABLE ENDOSCOPES MARKET: REGION FOOTPRINT       165

TABLE 160            DISPOSABLE ENDOSCOPES MARKET: TYPE FOOTPRINT       166

TABLE 161            DISPOSABLE ENDOSCOPES MARKET: APPLICATION FOOTPRINT         167

TABLE 162            DISPOSABLE ENDOSCOPES MARKET: END-USER FOOTPRINT            167

TABLE 163            DISPOSABLE ENDOSCOPES MARKET: DETAILED LIST OF KEY STARTUPS/SMES             169

TABLE 164            DISPOSABLE ENDOSCOPES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES                 171

TABLE 165            DISPOSABLE ENDOSCOPES MARKET: PRODUCT LAUNCHES & APPROVALS,  JANUARY 2022–OCTOBER 2025                 173

TABLE 166            DISPOSABLE ENDOSCOPES MARKET: DEALS, JANUARY 2022–OCTOBER 2025   176

TABLE 167            DISPOSABLE ENDOSCOPES MARKET: EXPANSIONS,

JANUARY 2022–OCTOBER 2025   178

TABLE 168            AMBU A/S: COMPANY OVERVIEW             179

TABLE 169            AMBU A/S: PRODUCTS OFFERED              180

TABLE 170          AMBU A/S: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–SEPTEMBER 2025                181

TABLE 171            AMBU A/S: EXPANSIONS, JANUARY 2022–JULY 2025        183

TABLE 172            BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW   185

TABLE 173            BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED    186

TABLE 174            BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,

JANUARY 2022–SEPTEMBER 2025                187

TABLE 175            BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JULY 2025               187

TABLE 176            OLYMPUS CORPORATION: COMPANY OVERVIEW          189

TABLE 177            OLYMPUS CORPORATION: PRODUCTS OFFERED             190

TABLE 178            OLYMPUS CORPORATION: PRODUCT APPROVALS,

JANUARY 2022–SEPTEMBER 2025                190

TABLE 179            OLYMPUS CORPORATION: DEALS, JANUARY 2022–SEPTEMBER 2025   191

TABLE 180            HOYA CORPORATION: COMPANY OVERVIEW                 192

TABLE 181            HOYA CORPORATION: PRODUCTS OFFERED                 193

TABLE 182            HOYA CORPORATION: DEALS, JANUARY 2022–SEPTEMBER 2025              194

TABLE 183            VERATHON INC.: COMPANY OVERVIEW                 195

TABLE 184            VERATHON INC.: PRODUCTS OFFERED 195

TABLE 185            VERATHON INC.: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025                196

TABLE 186            KARL STORZ SE & CO. KG: COMPANY OVERVIEW                 198

TABLE 187            KARL STORZ SE & CO. KG: PRODUCTS OFFERED                 198

TABLE 188          KARL STORZ SE & CO. KG: PRODUCT LAUNCHES,

JANUARY 2022–SEPTEMBER 2025                199

TABLE 189            KARL STORZ SE & CO. KG: DEALS, JANUARY 2022–SEPTEMBER 2025   199

TABLE 190            HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW       200

TABLE 191            HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.: PRODUCTS OFFERED        200

TABLE 192            HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.: DEALS,

JANUARY 2022– SEPTEMBER 2025               202

TABLE 193            INNOVEX MEDICAL CO., LTD.: COMPANY OVERVIEW          203

TABLE 194            INNOVEX MEDICAL CO., LTD.: PRODUCTS OFFERED             203

TABLE 195            SCIVITA MEDICAL: COMPANY OVERVIEW                 205

TABLE 196            SCIVITA MEDICAL: PRODUCTS OFFERED                 205

TABLE 197            GUANGZHOU RED PINE MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW 206

TABLE 198            GUANGZHOU RED PINE MEDICAL INSTRUMENT CO., LTD.: PRODUCTS OFFERED 206

TABLE 199            THE COOPER COMPANIES, INC.: COMPANY OVERVIEW          207

TABLE 200            ZHUHAI PUSEN MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW       208

TABLE 201            UROVIU CORPORATION: COMPANY OVERVIEW                 209

TABLE 202            OTU MEDICAL: COMPANY OVERVIEW   210

TABLE 203            GI VIEW LTD.: COMPANY OVERVIEW     211

TABLE 204            TSC LIFE: COMPANY OVERVIEW               212

TABLE 205            RICHARD WOLF GMBH: COMPANY OVERVIEW                 213

TABLE 206            DAICHUAN MEDICA: COMPANY OVERVIEW                 214

TABLE 207            NEOSCOPE INC.: COMPANY OVERVIEW 215

TABLE 208            INTEGRATED ENDOSCOPY: COMPANY OVERVIEW          216

TABLE 209            HUGER MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW   216

TABLE 210            XENOCOR: COMPANY OVERVIEW            217

TABLE 211            MACROLUX MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW   218

TABLE 212            SHENZHEN HUGEMED MEDICAL TECHNICAL DEVELOPMENT CO., LTD.:

COMPANY OVERVIEW   219

TABLE 213            ZHEJIANG GEYI MEDICAL DEVICES CO., LTD.: COMPANY OVERVIEW   220

TABLE 214            DISPOSABLE ENDOSCOPES MARKET: STUDY ASSUMPTIONS  233

TABLE 215            DISPOSABLE ENDOSCOPES MARKET: RISK ASSESSMENT ANALYSIS 234

LIST OF FIGURES

FIGURE 1              DISPOSABLE ENDOSCOPES MARKET SEGMENTATION & REGIONAL SCOPE    26

FIGURE 2              KEY INSIGHTS & MARKET HIGHLIGHTS 29

FIGURE 3              DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2025–2030 (USD MILLION)            29

FIGURE 4              MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET                 30

FIGURE 5              DISRUPTIVE TRENDS IMPACTING GROWTH OF DISPOSABLE ENDOSCOPES MARKET      31

FIGURE 6              HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN DISPOSABLE ENDOSCOPES MARKET, 2024                 32

FIGURE 7              NORTH AMERICA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD  33

FIGURE 8              RISING REQUIREMENT FOR ENDOSCOPY TO DIAGNOSE AND TREAT TARGET DISEASES TO DRIVE MARKET GROWTH             34

FIGURE 9              HOSPITALS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN DISPOSABLE ENDOSCOPES MARKET IN 2024  35

FIGURE 10            INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       36

FIGURE 11            NORTH AMERICA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD       36

FIGURE 12            DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING  FORECAST PERIOD                37

FIGURE 13            DISPOSABLE ENDOSCOPES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         38

FIGURE 14            DISPOSABLE ENDOSCOPES MARKET: PORTER’S FIVE FORCES ANALYSIS 44

FIGURE 15            DISPOSABLE ENDOSCOPES MARKET: SUPPLY CHAIN ANALYSIS              48

FIGURE 16            DISPOSABLE ENDOSCOPES MARKET: VALUE CHAIN ANALYSIS              50

FIGURE 17            DISPOSABLE ENDOSCOPES MARKET: ECOSYSTEM ANALYSIS  51

FIGURE 18            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           56

FIGURE 19            DISPOSABLE ENDOSCOPES MARKET: INVESTMENT & FUNDING SCENARIO     57

FIGURE 20            NUMBER OF PATENTS PUBLISHED (JANUARY 2015─OCTOBER 2025)    65

FIGURE 21            TOP APPLICANT COUNTRIES/REGIONS FOR DISPOSABLE ENDOSCOPES

(JANUARY 2015−OCTOBER 2025)              66

FIGURE 22            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DISPOSABLE ENDOSCOPES           76

FIGURE 23            KEY BUYING CRITERIA FOR TOP THREE DISPOSABLE ENDOSCOPES        77

FIGURE 24            DISPOSABLE ENDOSCOPES MARKET: GEOGRAPHIC SNAPSHOT            108

FIGURE 25            NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET SNAPSHOT       110

FIGURE 26            EUROPE: DISPOSABLE ENDOSCOPES MARKET SNAPSHOT          117

FIGURE 27            REVENUE ANALYSIS OF KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET (2020–2024)               160

FIGURE 28            MARKET SHARE ANALYSIS OF KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET (2024)         161

FIGURE 29            DISPOSABLE ENDOSCOPES MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       164

FIGURE 30            DISPOSABLE ENDOSCOPES MARKET: COMPANY FOOTPRINT 165

FIGURE 31            DISPOSABLE ENDOSCOPES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                 169

FIGURE 32            EV/EBITDA OF KEY VENDORS   172

FIGURE 33            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF

KEY VENDORS  172

FIGURE 34            DISPOSABLE ENDOSCOPES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     173

FIGURE 35            AMBU A/S: COMPANY SNAPSHOT (2024)                 180

FIGURE 36            BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024)      186

FIGURE 37            OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024)             190

FIGURE 38            HOYA CORPORATION: COMPANY SNAPSHOT (2024)    193

FIGURE 39            RESEARCH DESIGN         221

FIGURE 40            PRIMARY SOURCES         224

FIGURE 41            PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION                 226

FIGURE 42            MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS            227

FIGURE 43            TOP-DOWN APPROACH                228

FIGURE 44            BOTTOM-UP APPROACH              228

FIGURE 45            IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)              230

FIGURE 46            DISPOSABLE ENDOSCOPES MARKET: CAGR PROJECTIONS   230

FIGURE 47            DATA TRIANGULATION METHODOLOGY                 232

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧